Stay updated on NEBULAMB Clinical Trial

Sign up to get notified when there's something new on the NEBULAMB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NEBULAMB Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:05:46.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed evaluation criteria for a therapeutic strategy in treating Allergic Bronchopulmonary Aspergillosis (ABPA) and the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    22%
    Check dated 2025-04-16T16:46:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T10:58:40.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T14:33:54.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T22:35:55.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T15:28:01.000Z thumbnail image

Stay in the know with updates to NEBULAMB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NEBULAMB Clinical Trial page.